Related Experiment Video

Updated: Jun 1, 2026

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications

Roberta Ciarapica1, Lucio Miele, Antonio Giordano

  • 1Department of Oncohematology, IRCCS, Ospedale Pediatrico Bambino Gesù, Roma, Italy. roberta.ciarapica@yahoo.com

BMC Medicine
|May 26, 2011
PubMed

Insights

Investigating enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas reveals its potential role in tumor development. Targeting EZH2 offers a promising avenue for novel epigenetic therapies against these challenging childhood cancers.

Area of Science:

  • Pediatric oncology
  • Epigenetics
  • Cancer biology

Background:

  • Soft tissue sarcomas in children are diverse tumors originating from mesenchymal stem cells.
  • Current treatments like surgery and chemotherapy have limited efficacy due to resistance.
  • Epigenetic dysregulation, particularly involving chromatin modification, is implicated in sarcoma development.

Purpose of the Study:

  • To review the recently reported functions of enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas.
  • To discuss the hypothesis that EZH2 expression contributes to soft tissue sarcoma pathogenesis.
  • To explore the therapeutic potential of targeting EZH2 in epigenetic therapies.

Main Methods:

  • Literature review of recent studies on EZH2 in soft tissue sarcomas.
  • Analysis of EZH2's role in epigenetic regulation and stem cell differentiation.
  • Discussion of EZH2's involvement in soft tissue sarcomagenesis.

Main Results:

  • EZH2, a key epigenetic regulator, is implicated in maintaining an embryonic stem cell signature.
  • Deregulated expression and function of EZH2 have been observed in soft tissue sarcomas.
  • EZH2's activity represses genes crucial for stem cell differentiation.

Conclusions:

  • EZH2 plays a significant role in the epigenetic landscape of soft tissue sarcomas.
  • EZH2 deregulation is a potential driver of soft tissue sarcomagenesis.
  • Modulating EZH2 activity through epigenetic therapies presents a promising therapeutic strategy for pediatric soft tissue sarcomas.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...